| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Vignola Mark J. is a Chief Financial Officer at Terns Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 5 buys and 3 sells.
Estimated insider holdings value: $4.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 6, 2025 | TERN Terns Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 17,188 | $5.76 | $99,023.52 | -9.8% | -65.0% | +571.1% | |
| Sep 10, 2024 | TERN Terns Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 10,000 | $11.00 | $110,000.00 | -9.8% | -41.4% | -33.5% | |
| May 31, 2024 | TERN Terns Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 4,791 | $4.44 | $21,272.04 | +5.5% | +27.8% | -48.3% | |
| Nov 30, 2023 | TERN Terns Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 743 | $3.78 | $2,808.54 | +4.2% | +68.3% | +40.2% | |
| May 31, 2023 | TERN Terns Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 9,997 | $1.41 | $14,095.77 | +130.5% | -48.2% | -33.8% | |
| Nov 30, 2022 | TERN Terns Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 3 | $1.41 | $4.23 | - | +30.4% | -42.7% | |
| May 31, 2022 | TERN Terns Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 7,656 | $1.47 | $11,254.32 | New | +145.7% | +513.3% |